| JPM PACIFIC EQUITY I (ACC) USD | RVI ASIA PACÍFICO | 18,48% | 61,50% | 23,60% | 139,06% |
| POLAR CAPITAL BIOTECHNOLOGY I GBP DIS | RVI BIOTECNOLOGÍA | 18,48% | 91,26% | 73,80% | 321,11% |
| ROBECO BP US SELECT OPPORTUNITIES EQUITIES I EUR | RVI USA SMALL/MID CAP | 18,48% | 45,98% | 55,69% | 157,16% |
| SCHRODER ISF FRONTIER MARKETS EQUITY A ACC USD | RVI EMERGENTES | 18,48% | 72,39% | 87,61% | 162,34% |
| AB SICAV I-INTERNATIONAL HEALTH CARE PORTFOLIO C EUR | RVI SALUD | 18,47% | 15,13% | 23,94% | 136,94% |
| GVC GAESCO CROSSOVER / GLOBAL TOP-DOWN 3 SECTORES A | MIXTO FLEXIBLE | 18,47% | · | · | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 18,47% | 32,60% | -19,27% | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 18,47% | 32,56% | -19,31% | · |
| MIRALTA NARVAL EUROPA, FI F | RVI EUROPA | 18,47% | 102,18% | 111,32% | · |
| SCHRODER ISF FRONTIER MARKETS EQUITY A ACC SGD | RVI EMERGENTES | 18,47% | 72,55% | · | · |
| SCHRODER ISF GLOBAL CLIMATE LEADERS A ACC USD | RVI GLOBAL | 18,47% | 60,24% | · | · |
| SCHRODER ISF GLOBAL SUSTAINABLE GROWTH U ACC USD | RVI GLOBAL CRECIMIENTO | 18,47% | 47,23% | 42,08% | · |
| TRESSIS CAUDAL / NARCEA R | RVI GLOBAL | 18,47% | 56,61% | · | · |
| BNY MELLON SUSTAINABLE GLOBAL EQUITY FUND USD A (ACC) | RVI GLOBAL | 18,46% | 55,02% | 43,56% | 140,95% |
| INVESCO GLOBAL EQUITY INCOME Z CAP EUR | RVI GLOBAL | 18,46% | · | · | · |
| INVESCO GLOBAL FOCUS EQUITY Z CAP EUR | RVI GLOBAL VALOR | 18,46% | 63,93% | 23,73% | · |
| MFS MERIDIAN EMERGING MARKETS EQUITY FUND WH1-GBP | RVI EMERGENTES | 18,46% | 82,07% | 33,20% | 95,80% |
| UBS (LUX) STRATEGY SICAV - SYSTEMATIC ALLOCATION PORTFOLIO DYNAMIC (USD) Q-ACC | MIXTO FLEXIBLE | 18,46% | 40,59% | 32,54% | · |
| BBVA GLOBAL DESARROLLO, FI A | RVI GLOBAL | 18,45% | 55,85% | 49,95% | 147,55% |
| BGF ASIAN DRAGON C2 EUR | RVI ASIA EX-JAPÓN | 18,45% | 49,63% | 19,32% | 68,39% |
